How the Segal Cancer Centre is responding to the coronavirus pandemic
The Segal Cancer Centre at the JGH has responded to COVID-19 with compassion and innovation by enabling patients can consult with oncologists by video as an alternative to face-to-face meetings.
French cancer experts explore JGH research and care
The Jewish General Hospital’s French connection has been strengthened with the visit of six senior members of staff from the Regional Cancer Centre of the University Hospital Centre of Poitiers.
Pioneering effort to apply novel biotechnology to cancer research
The effort to find new biomarkers for cancer has received a major boost with the recent arrival at Lady Davis Institute of Dr. Christoph Borchers and the development of the first pan-Canadian proteomics program.